PhaseBio Announces Interim Analysis of REVERSE-IT Phase 3 Trial Accepted for Late Breaking Science Presentation at the American Heart Association Scientific Sessions 2021
Stock Information for PhaseBio Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.